MAIA Biotechnology (MAIA) Projected to Post Earnings on Thursday

MAIA Biotechnology (NYSEAMERICAN:MAIA) is projected to issue its quarterly earnings results before the market opens on Thursday, March 20th. Analysts expect the company to announce earnings of ($0.20) per share for the quarter.

MAIA Biotechnology Price Performance

MAIA Biotechnology stock opened at $1.67 on Wednesday. The firm has a 50 day simple moving average of $1.91. The stock has a market cap of $43.69 million, a price-to-earnings ratio of -1.21 and a beta of 0.20. MAIA Biotechnology has a 1-year low of $1.46 and a 1-year high of $5.99.

MAIA Biotechnology Company Profile

MAIA Biotechnology, Inc, a clinical stage biotechnology company, engages in the discovery, development, and commercialization of therapies targeting cancer. The company's lead product candidate is THIO, a telomere-targeting agent that is in Phase II clinical study to evaluate its activity in patients with non-small cell lung cancer.